DR. MARK ANDERSON
Dr. Mark Anderson, MD, PhD, is a professor and physician scientist in the UCSF Diabetes Center and a recognized expert in the genetic underpinnings of autoimmune diseases and the control of immune tolerance. He helped establish a genetic mouse model of APS1 to help understand how tolerance is disrupted in APS1 patients.
DR. RICHARD AUCHUS
Dr. Richard J. Auchus, Professor of Pharmacology and Internal Medicine, received his MD and PhD from Washington University. He completed training in internal medicine at the University of Iowa Hospitals and a fellowship in Endocrinology at the Wilford Hall USAF Hospital and the University of Texas Health Sciences Center in San Antonio. Dr. Auchus’ research includes clinical and translational investigation in disorders of the pituitary, adrenal, ovaries, and testes.
DR. MICHAIL S. LIONAKIS
Dr. Michail S. Lionakis, Chief, Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, obtained his MD and ScD from the University of Crete, Greece. He did clinical and research training at MD Anderson Cancer Center, Baylor College of Medicine, and NIH. His IRB-approved APS Type-1/APECED clinical research protocol aims to understand the mechanisms of autoimmunity and fungal susceptibility and improve diagnostic and therapeutic strategies for patients.
DR. DANA ORANGE
Dr. Dana Orange, MD, MSc, is an Assistant Professor at Rockefeller University and received her medical degree from Weill Cornell Medical College, Cornell University, and her MSc from Rockefeller University. She completed her Internal Medicine Residency at New York Presbyterian Hospital and her Rheumatology Fellowship at the Hospital for Special Surgery. Dr. Orange is facilitating research on APS Type 1 as principal investigator of the APS Type 1 web-based registry, an IRB approved protocol.